Detalhe da pesquisa
1.
GPRC5D-Targeted CAR T Cells for Myeloma.
N Engl J Med
; 387(13): 1196-1206, 2022 09 29.
Artigo
Inglês
| MEDLINE | ID: mdl-36170501
2.
Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation.
Cytotherapy
; 26(5): 466-471, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38430078
3.
Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations.
J Allergy Clin Immunol
; 152(3): 815-817, 2023 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37367708
4.
Developing a membrane-proximal CD33-targeting CAR T cell.
J Immunother Cancer
; 12(5)2024 May 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38772686
5.
CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma.
Blood Adv
; 8(7): 1600-1611, 2024 Apr 09.
Artigo
Inglês
| MEDLINE | ID: mdl-37878808
6.
Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets.
Clin Cancer Res
; 28(23): 5149-5155, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-36170461